The change came after the device was reclassified to “simple” instead of “moderately complex”. Previously, an eye practice had to obtain CLIA certification through paperwork and a 20-hour CME course to use the device. Company shares were trading up at much as 80 percent after the announcement.
Related Articles on Ophthalmology:
Thyroid Eye Disease Sufferers Who Smoke More Likely to Need Surgery
Guidelines for Treatment Course of Age-Related Macular Degeneration Updated
BIOLASE Laser Technology Issued Patent to Treat Eye Conditions
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.